Neurogene : ASGCT NGN-401 Clinical Safety Poster
Preliminary Safety Results from the Ph1/2 Study of NGN-401, a Novel Regulated Gene Therapy for Rett Syndrome Suter B1, Lieberman D2, Benke T3,...
Source: marketscreener.com
Stay updated with breaking news from Toxicity Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preliminary Safety Results from the Ph1/2 Study of NGN-401, a Novel Regulated Gene Therapy for Rett Syndrome Suter B1, Lieberman D2, Benke T3,...